Brief: Royalty Pharma Says It Announces Pricing Of $2.0 Billion Of Senior Unsecured Notes
03/09/2025 01:32
Sept 2 (Reuters) - Royalty Pharma PLC RPRX.O: ROYALTY PHARMA ANNOUNCES PRICING OF $2.0 BILLION OF SENIOR UNSECURED NOTES ROYALTY PHARMA - $600 MILLION OF 4.450% NOTES DUE 2031 ROYALTY PHARMA - PRICES $500 MILLION OF 5.950% NOTES DUE 2055 ROYALTY PHARMA PLC - PRICES $900 MILLION NOTES DUE 2035 AT 5.200% Source text: ID:nGNX5Z0znj Further company coverage: RPRX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Royalty Pharma
See all newsAnalysis: Revolution Medicines' Europe efforts signal solo launch ambitions for cancer drug
U.S. STOCKS ON THE MOVE-Best Buy, Peloton, Apple
Royalty Pharma falls after Novartis' cholesterol drug fails in study
Brief: Royalty Pharma Announces Update On Novartis’ Phase 3 Topline Results For Pelacarsen
Teva's immune disorder drug meets main goal in mid-stage trial (updated)